RCEL

#3761
Avita Medical, Inc. Common Stock
5.60 USD
+14.05%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
5.60
5.60
년간 변동
3.22
10.29
일일 변동
+14.05%
월간 변동
+21.21%
6달 변화
+6.87%
년간 변동율
-35.33%
이전 종가
4.91
Open
5.60
Bid
Ask
Low
5.60
High
5.60
양
22
Open full chart

Financials

Overview 성명 Statistics
Quarterly Annual
  • Market Capitalization 171.54 M
  • Employee 226
  • Founded 1999
  • CEO James Corbett
  • Website www.avitamedical.com
  • Headquarter Delaware, United States
  • FIGI BBG00TD18T43
  • Industry Technology
총매출
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.98
Price to sales ratio
1.34

Avita Medical Inc

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia.

뉴스